Hydrocortisone sodium succinate
- Level
- Commodity
- Parent
- 51422400
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51422434This classification denotes a therapeutic hydrocortisone with the molecular formula C25H33O8.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 50LQB69S1Z, chemically known as 1,4-butanedioic acid (succinic acid) but more generally known as hydrocortisone sodium succinate, which bears US NIH Compound Identifier 1110. European Medicines Agency schedules Hydrocortisone sodium succinate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02569MIG. Most nations, for tariff and trade purposes, schedule hydrocortisone sodium succinate under HS 29372100 and SITC 54153. As of Q4 2014, HYDROCORTISONE SODIUM SUCCINATE remains US FDA's Preferred Term for this commodity. Hydrocortisone sodium succinate bears US NLM identifiers UMLS ID C0770560 and NCI Concept Code C1819. SMILES: C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)COC(=O)CCC(=O)[O-])O)C)O.[NA+].
Same parent
Under 51422400 · 37Activities that produce or sell this
KBLI · 9Inherited from family 51420000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.